Unlisted
| Company Name | 주식회사 큐로셀 |
| English Name | Curocell Inc. |
| Business Reg. No. | 1488800557 |
| CEO | 김건수 |
| Address | 대전광역시 유성구 국제과학16로 11 |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 70113 |
| Established | Contact |
| Phone | 042-863-3698 |
| Website | curocellbtx.com |
| Regular Employees | 146persons |
| Corp. Reg. No. | 1311110466283 |
Venture Certified
| 벤처투자유형 | 2017-03-30 ~ 2019-03-29 | 20170300145 | 2017-03-30 |
| 벤처투자유형 | 2019-03-30 ~ 2021-03-29 | 20190300236 | 2017-03-30 |
| 벤처투자유형 | 2021-03-30 ~ 2024-03-29 | 20210507010006 | 2017-03-30 |
| 벤처투자유형 | 2024-03-30 ~ 2027-03-29 | 20240508010016 | 2017-03-30 |
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.0B | 0.0B | 0.0B |
| Operating Profit | -366B | -311B | -214B |
| Net Profit | -382B | -297B | -389B |
| Total Assets | 720B | 1,050B | 880B |
| Total Liabilities | 426B | 459B | 1,356B |
| Total Equity | 294B | 591B | -476B |
Operating Loss: Op. profit -366B
3 Consecutive Years of Net Loss
Debt Ratio Surge (+67pp YoY)
- 0.0%
▼ 39.4%
▲ 239.6%
▼ 924.7%
| Name | Position | Role |
|---|---|---|
| 김건수 | 대표이사 | 대표 |
| NPS Subscribers | 146persons |
| CEO | 김건수 |
| Est. Avg. Annual Salary | 4,87010K (40610K/mo) |
| Hired (12 mo) | +6persons |
| Left (12 mo) | -1persons |
| Net Change (12 mo) | +5persons |
| NPS Join Date | 2017-02-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "대전광역시 유성구",
"ceo_name": "김건수",
"certificate": [
{
"cert_number": "20170300145",
"changes": "",
"disclosure_date": "2017-03-30",
"first_cert_date": "2017-03-30",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2017-03-30 ~ 2019-03-29"
},
{
"cert_number": "20190300236",
"changes": "",
"disclosure_date": "2019-03-28",
"first_cert_date": "2017-03-30",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2019-03-30 ~ 2021-03-29"
},
{
"cert_number": "20210507010006",
"changes": "",
"disclosure_date": "2021-05-07",
"first_cert_date": "2017-03-30",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2021-03-30 ~ 2024-03-29"
},
{
"cert_number": "20240508010016",
"changes": "",
"disclosure_date": "2024-05-08",
"first_cert_date": "2017-03-30",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2024-03-30 ~ 2027-03-29"
}
],
"company_name": "주식회사 큐로셀",
"financials": {
"2022": {
"capital_stock": 4703625000,
"cost_of_sales": 0,
"current_assets": 41397340000,
"current_liabilities": 106647940000,
"gross_profit": 0,
"net_income": -38885125000,
"net_income_bs": -38885125000,
"non_current_assets": 46590393000,
"non_current_liabilities": 28937680000,
"non_operating_expenses": 18426031000,
"non_operating_income": 965517000,
"operating_profit": -21424611000,
"revenue": 0,
"sga_expenses": 21424611000,
"total_assets": 87987733000,
"total_equity": -47597887000,
"total_liabilities": 135585620000
},
"2023": {
"capital_stock": 6806368000,
"cost_of_sales": 0,
"current_assets": 42786879000,
"current_liabilities": 3270412000,
"gross_profit": 0,
"net_income": -29663583000,
"net_income_bs": -29574854000,
"non_current_assets": 62182507000,
"non_current_liabilities": 42599434000,
"non_operating_expenses": 2961414000,
"non_operating_income": 4427584000,
"operating_profit": -31129753000,
"revenue": 0,
"sga_expenses": 31129753000,
"total_assets": 104969386000,
"total_equity": 59099540000,
"total_liabilities": 45869846000
},
"2024": {
"capital_stock": 7099647000,
"cost_of_sales": 0,
"current_assets": 12727055000,
"current_liabilities": 38750160000,
"gross_profit": 0,
"net_income": -38235077000,
"net_income_bs": -38235077000,
"non_current_assets": 59273673000,
"non_current_liabilities": 3815711000,
"non_operating_expenses": 2641306000,
"non_operating_income": 1025161000,
"operating_profit": -36618932000,
"revenue": 0,
"sga_expenses": 36618932000,
"total_assets": 72000728000,
"total_equity": 29434857000,
"total_liabilities": 42565871000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "3,000,000,000",
"changes": "3,000,000,000",
"date": "2020-07-15"
},
{
"amount": "6,000,000,000",
"changes": "6,000,000,000",
"date": "2020-07-15"
},
{
"amount": "1,937,500,000",
"changes": "1,937,500,000",
"date": "2020-06-30"
},
{
"amount": "7,017,740,000",
"changes": "7,017,740,000",
"date": "2019-01-21"
}
],
"phone": "042-863-****",
"source": "pg_migration"
}{
"address": "대전광역시 유성구 국제과학16로",
"brno": "148880****",
"cappedWarning": false,
"companyName": "주식회사 큐로셀",
"estimatedAvgAnnualSalary": 48697092,
"estimatedAvgMonthlySalary": 4058091,
"fetchedAt": "2026-03-05T11:13:58.543Z",
"industryCode": "730000",
"industryName": "기타 인문 및 사회과학 연구개발업",
"joinDate": "20170201",
"last12MonthsHired": 6,
"last12MonthsLeft": 1,
"last12MonthsNetChange": 5,
"leaveDate": null,
"monthlyPensionAmount": 56285720,
"monthlyTrend": [
{
"lostSubscribers": 1,
"newSubscribers": 6,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6774495",
"status": "1",
"styleCode": "1",
"subscriberCount": 146,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Not Collected | Not Collected |
| Officers | DART | Collected |
| Employment | Public Data | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-26 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |